DX-8951f in Treating Patients With Biliary Cancer
NCT00005938
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
Liver Cancer
Interventions
DRUG:
exatecan mesylate
Sponsor
Daiichi Sankyo